Cepheid provides molecular diagnostic testing for various health conditions, including infectious diseases and oncology. It offers diagnostic systems and services to healthcare professionals.

Cepheid

Danaher Corporation

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com.

Cepheid is proud to be a part of Danaher. Danaher’s science and technology leadership puts Cepheid’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers.

Together with Danaher’s other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

U.S. Department of Defense

U.S. Department of Health & Human Services

Biomedical Advanced Research and Development Authority (BARDA)

Wheatley Partners

Innogenetics

Accurate detection of GroupA Strep supports antimicrobial stewardship and may reduce the number of patients inappropriately prescribed antibiotics. #RespiratoryHealth #StrepA

Learn more: https://lnkd.in/eRXv7Qu6

Cepheid receives expanded FDA clearance with CLIA Waiver for Xpert® Xpress MVP. We are committed to providing expanded access to #WomensHealth and #SexualHealth with PCR testing at the POC. Read all about it:

https://ow.ly/RKQu50QsbNg

There are approximately 11,500 new cases of cervical cancer diagnosed in the U.S. annually.* #CervicalCancerAwareness #MolecularDiagnostics 

*https://ow.ly/u42E50Qrv0i

Learn more about our Women’s Health and other testing solutions: https://ow.ly/Uqun50Qrv0h

Today we are honored to launch a new collaboration with the Innovative Genomics Institute (IGI) to develop a gene-editing solution designed to be easily modified to address potentially hundreds of devastating illnesses.

The Danaher-IGI Beacon for CRISPR Cures will take a revolutionary approach to genomic medicine, aiming to use CRISPR-based gene editing to permanently address the genetic causes of rare diseases with a unified technological approach.

By combining the R&D and manufacturing talent, technology and expertise of several Danaher businesses with the complementary academic research strengths at the IGI, we are dedicated to delivering on the enormous therapeutic promise of CRISPR for patients. https://bit.ly/48K8YbA

Aldevron Beckman Coulter Life Sciences Cytiva Integrated DNA Technologies Leica Biosystems Leica Microsystems Jennifer Doudna Fyodor Urnov

Cepheid is committed to providing expanded access to women’s and #sexualhealth with PCR testing at the POC. We’re excited to introduce Xpert® Xpress MVP, a multiplex vaginal panel to aid in the diagnosis of Bacterial Vaginosis, Vulvovaginal Candidiasis, and Trichomoniasis for use in near-patient settings, with results in as soon as 60 min. Learn more: https://ow.ly/yjUt50QnTr7

Happy New Year. We wish you a happy, healthy, and peaceful 2024.

Hosting the Mayor of Markham, Ontario, Frank Scarpitti, at Cepheid Canada this month was a pleasure. Thank you for sharing our passion for innovation and improving patient outcomes with real-time PCR. #BestTeamWins #Cepheid #MolecularDiagnostics #MultiplexPCR #LabInACartridge

Wishing you all the joys of the season and happiness throughout the coming year. Best wishes from your friends at Cepheid.

BD (Becton, Dickinson and Company) is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents.

Illumina is a leading company in the field of genomics and genetic analysis, providing sequencing and array-based solutions for genetic analysis.

Illumina

Bio-Rad Laboratories is a global leader in life science research and clinical diagnostics, offering a wide range of products for the healthcare and life sciences industries.

Bio-Rad

Biomeme is a company that provides a portable qPCR system for real-time genetic testing, including targeted test kits for identifying pathogens and diseases based on DNA or RNA signatures.

Biomeme

Danaher Corporation is a global science and technology innovator committed to helping customers solve complex challenges and improve quality of life around the world.

Cepheid is an American molecular diagnostics company that specializes in automated nucleic acid tests for identifying and analyzing pathogens and genetic disorders. The company sells clinical tests for healthcare-associated infections, infectious diseases, sexual health, oncology, and genetics.

news impact assignment basic	general	Feb 15, 2024 3:10 PM	cbf4afde
public peers	general	Oct 2, 2024 2:09 PM	6c4b3b79
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Oct 9, 2024 3:05 AM	ecf1f8cf
company summary	general
signals	general	Oct 2, 2024 2:09 PM	af71e4e1
crunchbase trigger	general
crunchbase profile	general
li profile	general	Feb 15, 2024 3:10 PM	26e69c27
translate crunchbase fundingrounds	general
peers	general	Oct 2, 2024 2:09 PM	bfee142b
news basic	general	Oct 2, 2024 2:09 PM	669294ea
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:CEPHEID

Cepheid